Navigation Links
New statin guidelines an improvement, Yale study shows
Date:8/26/2014

New Haven, Conn. New national guidelines can improve the way statin drugs are prescribed to patients at risk for cardiovascular disease, a Yale University study has found.

The research, published Aug. 25 in the Journal of the American College of Cardiology, also showed the new guidelines produce only a modest increase in the number of patients being given the drugs.

Statins are a class of drugs that help lower cholesterol by blocking the enzyme HMG-CoA reductase, which the body needs in order to produce cholesterol. Common statin medications include Lipitor, Levacor, Zocor, Pravachol, and Crestor.

In 2013, the American Heart Association and the American College of Cardiology jointly published a new set of standards for the assessment of cardiovascular risk. The standards replaced the 2001 National Cholesterol Education Program Adult Treatment Panel III recommendations.

"There has been a great deal of discussion about the new guidelines. People worry whether the new risk equation is accurate," said Dr. Kevin M. Johnson, lead author of the study and associate professor of diagnostic radiology at the Yale School of Medicine. "They are concerned that too many people will be put on statins."

Johnson and co-author Dr. David A. Dowe of Atlantic Medical Imaging, in Galloway, N.J., studied 3,076 subjects. They applied both sets of guidelines to determine whether patients would start statin therapy.

They found that the new guidelines did a better job of discriminating between patients with little or no plaque and those with more plaque. Of patients with heavy plaque, 92% would be assigned to statin therapy under the new method, but only 53% under the old standards.

The biggest difference between the two results, researchers said, was the use of low-density lipoprotein (LDL) cholesterol targets under the old guidelines. The targets "seriously degraded the accuracy of the NCEP guideline for statin assignment," according to the study.

"The old guidelines emphasized lowering LDL cholesterol to certain target values, but the new guidelines have done away with that approach," Johnson said. "Many doctors are reluctant to give up targets."

Overall, 15% more patients would be put on statins under the new guidelines considerably fewer than some observers had predicted, he added.

The researchers noted that they used coronary atherosclerotic plaque burden as the determining factor in the study, rather than cardiac events. Further study will be necessary to evaluate the guidelines with outcome data.


'/>"/>

Contact: Jim Shelton
james.shelton@yale.edu
203-432-3881
Yale University
Source:Eurekalert

Related medicine news :

1. Benefits of Widespread Statin Use Outweigh Risks: Study
2. Statins prevent cancer in heart transplant recipients
3. Statins May Help Prevent Enlarged Prostate: Study
4. Pivotal role for proteins -- from helping turn carbs into energy to causing devastating disease
5. Are Statins Less Helpful for Women?
6. Turning off key piece of genetic coding eliminates toxic effect of statins, SLU research finds
7. Statins Heart Benefits Outweigh Diabetes Risk: Study
8. Statins Wont Hurt, Might Even Help, Your Pancreas: Study
9. Statin Use Tied to Possible Boost in Cataract Risk
10. New Drug May Help Those Who Cant Take Statins
11. Looking for the anti-Alzheimers molecule -- A new approach to treating a devastating disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/26/2016)... Cary, North Carolina (PRWEB) , ... June 26, 2016 , ... ... the release of a new product that was developed to enhance the health of ... harvested for centuries. , The two main herbs in the PawPaws Cat Kidney ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... America . ... ... ... ...
(Date:6/23/2016)... FRANKLIN, Tenn. , June 23, 2016 ... for automating, integrating and transforming the patient ... launch of several innovative new products and ... depth of its revenue cycle offerings. These ... establish more efficient workflows, remain compliant in ...
Breaking Medicine Technology: